This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS
by Zacks Equity Research
Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS
One of Your Stock Investments is Being Acquired: Now What?
by Tracey Ryniec
One of your companies gets a buyout offer and the shares soar. There might be different strategies for traders and investors on what to do next.
What's in Store for SmileDirectClub's (SDC) Q4 Earnings?
by Zacks Equity Research
SmileDirectClub (SDC) is likely to have gained from a strong international presence in Q4.
Top Stock Analyst Reports for Apple, American Express & Starbucks
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), American Express (AXP) and Starbucks (SBUX).
Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - February 13, 2020
by Zacks Equity Research
Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.
The Federal Budget in Focus
by Zacks Equity Research
The Federal Budget in Focus
CVS Health (CVS) Q4 Earnings Top Estimates, Margins Improve
by Zacks Equity Research
CVS Health (CVS) registers strong growth in Pharmacy Services, benefiting from the upside in specialty services.
Shopify, CVS Outperform in Q4, Plus COVID-19 Update
by Mark Vickery
Shopify (SHOP) impressed investors with a big beat on both top and bottom lines: 43 cents per share versus 23 cents expected, on $505.2 million which easily surpassed the Zacks consensus $482.3 million.
Can Pharmacy Services Growth Aid CVS Health (CVS) Q4 Earnings?
by Zacks Equity Research
Expanded claims volume and better purchasing economics are expected to have aided CVS Health's (CVS) top line in Q4.
CVS Health (CVS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $67.88, marking a +1.42% move from the previous day.
Pharmacies & Drug Stores Industry Outlook: Prospects Mixed
by Urmimala Biswas
The Retail - Pharmacies and Drug Stores industry is known for heavy consolidations.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $70.55, marking a -1.77% move from the previous day.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $73.53 in the latest trading session, marking a -0.65% move from the prior day.
Why CVS Health (CVS) Could Beat Earnings Estimates Again
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies
CVS Health's Selling Seasons Strong, Omnicare Arm Upsets
by Zacks Equity Research
CVS Health's (CVS) 2020 PBM selling season remains strong with gross new business and net new business wins.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $72.76, marking a +0.9% move from the previous day.
Top Research Reports for UnitedHealth, CVS & Morgan Stanley
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group (UNH), CVS Health (CVS) and Morgan Stanley (MS).
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $73.86, moving +0.39% from the previous trading session.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $74.29, marking a +0.8% move from the previous day.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $74.51, marking a +0.17% move from the previous day.
Rite Aid (RAD) Earnings Surpass Estimates in Q3, Stock Up
by Zacks Equity Research
Rite Aid (RAD) posts robust results in third-quarter fiscal 2020. Notably, the bottom line benefits from higher adjusted EBITDA in the quarter.
Walgreens is the Worst Dow Stock Now, Will 2020 Be Different?
by Zacks Equity Research
Despite the dismal performance in recent times, Walgreens (WBA) has chances to bounce back in 2020.
HMO Industry Outlook: Multiple Levers to Drive Growth
by Sapna Bagaria
Aging U.S population, consolidation, use of technology and growing health service businesses provide ample scope for the industry to grow.